OCT 22, 2020
Jeffrey Goldberg, MD, PhD, Blumenkranz Smead professor and chair of ophthalmology at Stanford University, has been elected to the National Academy of Medicine (NAM).
Dr. Goldberg was recognized for his contributions in the understanding of the survival and axon growth of retinal ganglion cells relevant to neuroprotection and regeneration. Other notable contributions include his work in biomarker development and vision restoration clinical trials in glaucoma and other eye diseases.
“I am deeply honored to be elected to the National Academy of Medicine,” Dr. Goldberg said in a Stanford press release. “I look forward to serving the goals of the National Academies, and to continuing my collaborative research efforts with my colleagues at the Byers Eye Institute at Stanford and around the world as we further our efforts to combat needless blindness.”
In addition to his position as department chair, Dr. Goldberg serves as director of the Mary M. and Sash A. Spencer Center for Vision Research at the Byers Eye Institute. He directs an NIH -funded research laboratory and has significant expertise in implementing clinical trials for optic nerve neuroprotection and regeneration. Under his leadership, his lab has made spectacular breakthroughs in the field of artificial retinas as well as advances in imaging technology for detecting damage at the level of individual photoreceptor cells. Dr. Goldberg's efforts have led to significant advances in diagnosing, tracking and treating degenerative diseases before irreversible damage is done.
“We congratulate Dr. Goldberg on this well-deserved distinction,” said Lloyd Minor, MD, Stanford’s dean of the school of medicine. “Dr. Goldberg is not only an innovative and creative clinician-scientist, but also a transformative leader in advocating for health, for education, and for equity, as evidenced by the many successes of the faculty and staff at the Byers Eye Institute at Stanford.